 |
PDBsum entry 5kty
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Sci Rep
6:33019
(2016)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural insights into Parkin substrate lysine targeting from minimal Miro substrates.
|
|
J.L.Klosowiak,
S.Park,
K.P.Smith,
M.E.French,
P.J.Focia,
D.M.Freymann,
S.E.Rice.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Hereditary Parkinson's disease is commonly caused by mutations in the protein
kinase PINK1 or the E3 ubiquitin ligase Parkin, which function together to
eliminate damaged mitochondria. PINK1 phosphorylates both Parkin and ubiquitin
to stimulate ubiquitination of dozens of proteins on the surface of the outer
mitochondrial membrane. However, the mechanisms by which Parkin recognizes
specific proteins for modification remain largely unexplored. Here, we show that
the C-terminal GTPase (cGTPase) of the Parkin primary substrate human Miro is
necessary and sufficient for efficient ubiquitination. We present several new
X-ray crystal structures of both human Miro1 and Miro2 that reveal substrate
recognition and ubiquitin transfer to be specific to particular protein domains
and lysine residues. We also provide evidence that Parkin substrate recognition
is functionally separate from substrate modification. Finally, we show that
prioritization for modification of a specific lysine sidechain of the cGTPase
(K572) within human Miro1 is dependent on both its location and chemical
microenvironment. Activation of Parkin by phosphorylation or by binding of pUb
is required for prioritization of K572 for modification, suggesting that Parkin
activation and acquisition of substrate specificity are coupled.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |